148 related articles for article (PubMed ID: 33174264)
1. Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis.
Haseler CJ; Jarvis GE; McGovern KF
Equine Vet J; 2021 Sep; 53(5):895-901. PubMed ID: 33174264
[TBL] [Abstract][Full Text] [Related]
2. Does oral prednisolone treatment increase the incidence of acute laminitis?
Jordan VJ; Ireland JL; Rendle DI
Equine Vet J; 2017 Jan; 49(1):19-25. PubMed ID: 26713748
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly.
Ryu SH; Kim BS; Lee CW; Yoon J; Lee YL
J Vet Sci; 2004 Sep; 5(3):271-4. PubMed ID: 15365245
[TBL] [Abstract][Full Text] [Related]
4. Comparison of equine synovial sepsis rate following intrasynovial injection in ambulatory versus hospital settings.
Krause DM; Pezzanite LM; Griffenhagen GM; Hendrickson DA
Equine Vet J; 2022 May; 54(3):523-530. PubMed ID: 34115426
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids.
Potter K; Stevens K; Menzies-Gow N
Vet Rec; 2019 Jul; 185(3):82. PubMed ID: 31175222
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical signs of owner-reported equine laminitis in a cohort of horses and ponies in Great Britain.
Pollard D; Wylie CE; Newton JR; Verheyen KLP
Equine Vet J; 2019 Sep; 51(5):587-594. PubMed ID: 30516850
[TBL] [Abstract][Full Text] [Related]
7. Systemic absorption of triamcinolone acetonide is increased from intrasynovial versus extrasynovial sites and induces hyperglycemia, hyperinsulinemia, and suppression of the hypothalamic-pituitary-adrenal axis.
Hallowell KL; Dembek K; Horne CR; Knych HK; Messenger KM; Schnabel LV
Front Vet Sci; 2024; 11():1388470. PubMed ID: 38828366
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses.
French K; Pollitt CC; Pass MA
J Vet Pharmacol Ther; 2000 Oct; 23(5):287-92. PubMed ID: 11107002
[TBL] [Abstract][Full Text] [Related]
9. Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: A cohort study of free-text electronic medical records.
Welsh CE; Duz M; Parkin TDH; Marshall JF
Prev Vet Med; 2017 Jan; 136():11-18. PubMed ID: 28010903
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of fractures in 1488 Thoroughbred racehorses receiving intrasynovial medication: 2006-2011.
Smith LCR; Wylie CE; Palmer L; Ramzan PHL
Equine Vet J; 2018 Nov; 50(6):774-780. PubMed ID: 29575177
[TBL] [Abstract][Full Text] [Related]
11. Synovial sepsis is rare following intrasynovial medication in equine ambulatory practice.
Smith LCR; Wylie CE; Palmer L; Ramzan PHL
Equine Vet J; 2019 Sep; 51(5):595-599. PubMed ID: 30589107
[TBL] [Abstract][Full Text] [Related]
12. Clinical Research Abstracts of the British Equine Veterinary Association Congress 2015.
Hammersley E; Duz M; Marshall JF
Equine Vet J; 2015 Sep; 47 Suppl 48():24. PubMed ID: 26375178
[TBL] [Abstract][Full Text] [Related]
13. Descriptive epidemiological study of equine laminitis.
Slater MR; Hood DM; Carter GK
Equine Vet J; 1995 Sep; 27(5):364-7. PubMed ID: 8654351
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004).
Parsons CS; Orsini JA; Krafty R; Capewell L; Boston R
J Am Vet Med Assoc; 2007 Mar; 230(6):885-9. PubMed ID: 17362165
[TBL] [Abstract][Full Text] [Related]
15. Incidence of laminitis and survey of dietary and management practices in pleasure horses and ponies in south-eastern Australia.
Potter SJ; Bamford NJ; Harris PA; Bailey SR
Aust Vet J; 2017 Oct; 95(10):370-374. PubMed ID: 28948628
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, matched case-control study of risk factors for equine laminitis.
Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
[TBL] [Abstract][Full Text] [Related]
18. A cohort study of equine laminitis in Great Britain 2009-2011: estimation of disease frequency and description of clinical signs in 577 cases.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Equine Vet J; 2013 Nov; 45(6):681-7. PubMed ID: 23489181
[TBL] [Abstract][Full Text] [Related]
19. Assessment of horse owners' ability to recognise equine laminitis: A cross-sectional study of 93 veterinary diagnosed cases in Great Britain.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
Equine Vet J; 2017 Nov; 49(6):759-766. PubMed ID: 28543943
[TBL] [Abstract][Full Text] [Related]
20. Identification of modifiable factors associated with owner-reported equine laminitis in Britain using a web-based cohort study approach.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
BMC Vet Res; 2019 Feb; 15(1):59. PubMed ID: 30755193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
